Ambulatory Systolic Blood Pressure and Carotid Atherosclerosis in Type 2 Diabetes: A Critical Role of Glycemic

Hui Liu1, Qidong Zheng2, Hengjing Wu1

  • 1Clinical Center for Intelligent Rehabilitation Research, Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, People's Republic of China.

Insights

In poorly controlled type 2 diabetes, elevated systolic blood pressure (SBP) measured by ambulatory blood pressure monitoring (ABPM) is linked to carotid plaques. This highlights the importance of combined ABPM and HbA1c assessment for early vascular risk detection.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Medicine

Background:

  • Ambulatory blood pressure monitoring (ABPM) is crucial for cardiovascular risk assessment in diabetes.
  • The association between ABPM and early atherosclerosis, specifically carotid plaques, remains unclear in diabetic patients.

Purpose of the Study:

  • To investigate the relationship between ABPM parameters and the presence of carotid plaques in individuals with type 2 diabetes.
  • To stratify these associations based on glycated hemoglobin (HbA1c) levels.

Main Methods:

  • A cross-sectional observational study analyzed 498 patients with type 2 diabetes using 24-hour ABPM and carotid ultrasound.
  • Patients were stratified by HbA1c levels (<5.7%, 5.7-6.4%, >6.4%).
  • Logistic regression, adjusted for confounders, assessed associations between ABPM and carotid plaques.

Main Results:

  • Carotid plaque prevalence was 46.6% in the study population.
  • Elevated systolic blood pressure (SBP) by ABPM was significantly associated with carotid plaques only in patients with HbA1c ≥6.4%.
  • Specific associations included 24-hour SBP ≥130 mmHg (OR=2.14), awake SBP ≥135 mmHg (OR=1.87), and asleep SBP ≥120 mmHg (OR=1.78). No significant associations were found for diastolic BP or in lower HbA1c groups.

Conclusions:

  • In type 2 diabetes with poor glycemic control (HbA1c ≥6.4%), elevated SBP measured via ABPM is an independent predictor of carotid plaques.
  • Combined assessment of ABPM and HbA1c levels can aid in detecting early vascular risk.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
863
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
729
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
4
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.3K